Knowing When To Stop-Trapping Metastable Polymorphs in Mechanochemical Reactions

被引:32
|
作者
Kulla, Hannes [1 ,2 ]
Greiser, Sebastian [1 ]
Benemann, Sigrid [1 ]
Rademann, Klaus [2 ]
Emmerlingt, Franziska [1 ]
机构
[1] BAM Fed Inst Mat Res & Testing, Richard Willstatter Str 11, D-12489 Berlin, Germany
[2] Humboldt Univ, Dept Chem, Brook Taylor Str 2, D-12489 Berlin, Germany
关键词
X-RAY-DIFFRACTION; ACTIVE PHARMACEUTICAL INGREDIENTS; IN-SITU; REAL-TIME; COCRYSTAL FORMATION; CARBOXYLIC-ACIDS; SYSTEMATIC CONSTRUCTION; RELATIVE STABILITY; MILLING REACTIONS; CO-CRYSTAL;
D O I
10.1021/acs.cgd.6b01572
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The cocrystal formation of pyrazinamide (PZA) with malonic acid (MA) was studied in situ. The mechanochemical reaction proceeds via conversion of a crystalline intermediate (PZA:MA II) into the thermodynamically more stable form (PZA:MA I) upon further grinding. The information derived from in situ powder X-ray diffraction (PXRD) enabled the isolation of this new metastable polymorph. On the basis of the PXRD data, the crystal structure of the 1:1 cocrystal PZA:MA II was solved. The polymorphs were further characterized and compared by Raman spectroscopy, solid-state NMR spectroscopy, differential thermal analysis/thermogravimetric analysis, and scanning electron microscopy. Our study demonstrates how monitoring mechanochemical reactions by in situ PXRD can direct the discovery and isolation of even short-lived intermediates not yet accessed by conventional methods.
引用
收藏
页码:1190 / 1196
页数:7
相关论文
共 50 条
  • [41] Knowing when to stop: Aberrant precision and evidence accumulation in schizophrenia
    Limongi, Roberto
    Bohaterewicz, Bartosz
    Nowicka, Magdalena
    Plewka, Aleksandra
    Friston, Karl J.
    SCHIZOPHRENIA RESEARCH, 2018, 197 : 386 - 391
  • [42] Massive Transfusion: Knowing When to Stop Based on Target Hemoglobin
    Thomas, Ananda
    Adegboye, Janet
    Cruz, Nicolas
    Nicholson, Ryan
    Asiedu, Jessica
    Frank, Steven
    ANESTHESIA AND ANALGESIA, 2022, 135 (3S_SUPPL): : 17 - 18
  • [43] Knowing when to stop: MICL self-regulates neutrophil NETosis
    Shim, Hanjoo Brian
    Deniset, Justin Francois
    Kubes, Paul
    CELL RESEARCH, 2025, 35 (02) : 89 - 90
  • [45] Knowing when not to stop: rejecting futility in Ebola virus disease treatment
    Jacobs, Michael
    JOURNAL OF THE ROYAL ARMY MEDICAL CORPS, 2018, 164 (04) : 228 - 229
  • [46] Knowing when to stop: Loving and living small in the slave world of 'Beloved'
    Randle, GT
    CLA JOURNAL-COLLEGE LANGUAGE ASSOCIATION, 1998, 41 (03): : 279 - 302
  • [47] Knowing when to stop: How noise frees us from determinism
    Cvitanovic, Predrag
    Lippolis, Domenico
    LET'S FACE CHAOS THROUGH NONLINEAR DYNAMICS, 2012, 1468 : 82 - 126
  • [48] Knowing How to Stop: Ceasing Prescribing When the Medicine Is No Longer Required
    Ostini, Remo
    Hegney, Desley
    Jackson, Claire
    Tett, Susan E.
    JOURNAL OF MANAGED CARE PHARMACY, 2012, 18 (01): : 68 - 72
  • [49] Knowing When to Stop: Evaluation and Verification of Conformity to Output-size Specifications
    Wang, Chenglong
    Bunel, Rudy
    Dvijotham, Krishnamurthy
    Huang, Po-Sen
    Grefenstette, Edward
    Kohli, Pushmeet
    2019 IEEE/CVF CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION (CVPR 2019), 2019, : 12252 - 12261
  • [50] Cumulative doses of radioiodine in the treatment of differentiated thyroid carcinoma: knowing when to stop
    Martins-Filho, Raul
    Ward, Laura S.
    Amorim, Barbara J.
    Santos, Allan O.
    de Lima, Mariana C. L.
    Ramos, Celso D.
    Matos, Patricia S.
    Assumpcao, Ligia V. M.
    Camargo, Edwaldo E.
    Etchebehere, Elba C. S. C.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (09) : 807 - 812